AEGiS-NYT: Blood Plasma Is Withdrawn As AIDS Link New York TimesImportant note: Information in this article was accurate in 1983. The state of the art may have changed since the publication date.
Click here to return to Associated Press main menu
DonateNow


Blood Plasma Is Withdrawn As AIDS Link

The New York Times - November 2, 1983
Ronald Sullivan


An official of the Federal Food and Drug Administration said yesterday that a California blood product company withdrew 16 lots of a blood clotting factor used by hemophiliacs after it was discovered that it contained plasma drawn from a commercial blood donor in Texas who died last month of acquired immune deficiency syndrome, or AIDS.

Dr. Dennis Donohue, director of the division of blood products in the Office of Biologics, said the donor gave blood plasma at least 50 times in the last 11 months to a commercial blood center in Austin, Tex. The withdrawal involved about 64,000 doses.

Dr. Donohue, speaking at a Manhattan news conference organized by the American Association of Blood Banks, said the man had "lied" when asked by the center if he belonged to any of the high-risk groups that have been primarily identified with AIDS.

The fact that the man was a repeated donor was discovered when Jeri Moore, manager of the center, Austin Blood Components, said she heard news of the death of Christopher Whitfield at Brackenridge Hospital on Oct. 21. The hospital said he died of AIDS and had identified himself as a homosexual. Miss Moore recognized the victim as a well-known donor to her center. 2% of U.S. Supply

The center said it had sold its plasma to Cutter Laboraties Inc. of Emeryville, Calif. Bud Modersbach, a Cutter spokesman, said yesterday that the company had withdrawn 16 lots of blood clotting material that was traced to a large pool of plasma, which included plasma donated by Mr. Whitfield. He said the withdrawal, which represented from 2 to 3 percent of the nation's annual supply of the material, would not cause any shortage. Each lot contains 4,000 doses in small vials.

"We did this to assure the country's 15,000 to 20,000 hemophiliacs that we were taking every precaution even though there is no evidence that AIDS is transmitted this way," Mr. Modersbach said.

Hemophiliacs regularly require blood clotting factors derived from blood plasma to prevent uncontrolled bleeding. Commerical donors can give the material repeatedly because their red blood cells are returned to their body after the plasma is extracted.

According to the national Centers for Disease Control in Atlanta, there have been 2,577 cases of AIDS, and 1,072 deaths thus far. Nearly half of the cases have been reported in New York City.

The disorder, which destroys the body's immune system, leaving victims prey to a variety of fatal illnesses, is mostly confined to homosexuals and intravenous drug users.


831102
NYT831102


Copyright © 1983 - The New York Times Company. All Rights Reserved. All New York Times articles contained on the AEGiS web site are protected by United States copyright law and may not be reproduced, distributed, transmitted, displayed, published or broadcast without the prior written permission of The New York Times Company. You may not alter or remove any trademark, copyright or other notice from copies of the content. However, you may download articles (one machine readable copy and one print copy per page) for your personal, noncommercial use only.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, the Elton John AIDS Foundation, National Library of Medicine, and donations from users like you.

Always watch for outdated information. This article first appeared in 1983. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1983. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .